Prostate Cancer Cases Rising in Israel with Over 3,700 Diagnoses Projected for 2026
Prostate cancer cases in Israel are rising, with over 3,700 diagnoses projected for 2026. Experts emphasize lifestyle changes and early detection.
Prostate cancer, the most common malignant disease among men, is on the rise in Israel, according to data released by the Israel Cancer Association. Projections indicate that by the end of 2026, approximately 3,725 men will be diagnosed with the disease, with an estimated 538 deaths expected over the course of the year. These figures were published ahead of International Prostate Cancer Awareness Day.
Rising Statistics and Future Projections
Data from the National Center for Disease Control at the Ministry of Health point to an annual increase of 3.8% in the incidence of the disease among Jewish men between 2015 and 2022, and a 2.8% annual increase among Arab men from 2016 to 2022. Because data registration for subsequent years is not yet complete, the 2026 figures remain an estimate.
Looking further ahead, the International Agency for Research on Cancer of the World Health Organization projects that by the year 2050, approximately 4,710 men in Israel will be diagnosed with prostate cancer, and about 1,150 men are expected to die from the disease that year.
Lifestyle Recommendations and Research Insights
"Prostate cancer is the most common form among men, but the forecast for continued growth in patient numbers is not a decree of fate," said Moshe Bar-Chaim, CEO of the Israel Cancer Association.
The association recommends incorporating regular physical activity into daily routines, maintaining a healthy body weight, and adopting a Mediterranean diet rich in vegetables, fruits, and dietary fiber. Additionally, experts advise avoiding smoking, reducing alcohol consumption, and limiting processed foods and red meat.
Recent studies have further illuminated the connection between lifestyle habits and disease risk. A Finnish review combining six cohort studies involving 82,570 men found that compared to non-drinkers, the likelihood of developing prostate cancer increased by 18% among those consuming fewer than five drinks per week, 20% for those consuming five to fourteen drinks, and 32% for those consuming fourteen or more drinks weekly.
Early Detection and High-Risk Groups
Prostate cancer is particularly common among men aged 60 and older. While many tumors progress slowly and do not cause symptoms or require immediate treatment, others can develop rapidly and spread to other organs. According to the association, approximately 75% of cases are diagnosed at an early stage while still localized.
The Israel Cancer Association recommends that men consult their health maintenance organizations for genetic counseling and potential testing referrals if a family member carries a BRCA gene mutation, or if there is a history of breast, ovarian, prostate, or pancreatic cancer within the family. These recommendations also apply to men diagnosed with prostate cancer at a young age or those with Lynch syndrome.
